Form D · Pharmaceuticals
FEMTA PHARMACEUTICALS, INC.
San Diego, CA · CIK 0001468246
Offering snapshot reported Jul 13, 2010 · SEC filing
- Reported sold
- $2.2M Offering amount: $2.47M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2010 | Initial | $2,200,005 | No comparison | 5 | SEC filing |
| Nov 13, 2009 | Initial | $500,000 | No comparison | 3 | SEC filing |
| Jul 16, 2009 | Initial | $1,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144795
Warrants to purchase Series A Preferred Stock with an aggregate exercise price of $270,000 were issued in connection with the offering but are unexercised to date.
Source: Form D, filed Jul 13, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Keane | Director, Executive |
| Per Peterson | Director |
| Jay Short | Director |
| Kenneth Widder | Director |
| Jim Woody | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4510 Executive Drive, Suite 322
San Diego, CA, 92121
San Diego, CA, 92121